GLOBUS MEDICAL, INC. Net Income (Loss) Available to Common Stockholders, Diluted
GLOBUS MEDICAL, INC. (GMED) reported Net Income (Loss) Available to Common Stockholders, Diluted of $102.98 million for the 12-month period ending 2024-12-31, per its 10-K filed 2025-02-20.
Financial Statements › Income Statement › Net Income
us-gaap:NetIncomeLossAvailableToCommonStockholdersDiluted · last filed 2025-02-20
- GLOBUS MEDICAL, INC. net income (loss) available to common stockholders, diluted for the quarter ending 2024-12-31 was $26.50M, a 80.67% increase year-over-year.
- GLOBUS MEDICAL, INC. net income (loss) available to common stockholders, diluted for the quarter ending 2024-09-30 was $51.84M, a 5093.99% increase year-over-year.
- GLOBUS MEDICAL, INC. net income (loss) available to common stockholders, diluted for the quarter ending 2024-06-30 was $31.76M, a 44.97% decline year-over-year.
- GLOBUS MEDICAL, INC. net income (loss) available to common stockholders, diluted for the quarter ending 2024-03-31 was -$7.12M, a 114.49% decline year-over-year.
- GLOBUS MEDICAL, INC. net income (loss) available to common stockholders, diluted for fiscal 2024 was $102.98M, a 16.19% decline from fiscal 2023.
- GLOBUS MEDICAL, INC. net income (loss) available to common stockholders, diluted for fiscal 2023 was $122.87M, a 35.39% decline from fiscal 2022.
- GLOBUS MEDICAL, INC. net income (loss) available to common stockholders, diluted for fiscal 2022 was $190.17M, a 27.47% increase from fiscal 2021.
- GLOBUS MEDICAL, INC. net income (loss) available to common stockholders, diluted for fiscal 2021 was $149.19M.
| Period end | Net Income (Loss) Available to Common Stockholders, Diluted 3 month | Net Income (Loss) Available to Common Stockholders, Diluted 3 month as first filed | Net Income (Loss) Available to Common Stockholders, Diluted 6 month | Net Income (Loss) Available to Common Stockholders, Diluted 6 month as first filed | Net Income (Loss) Available to Common Stockholders, Diluted 9 month | Net Income (Loss) Available to Common Stockholders, Diluted 12 month |
|---|---|---|---|---|---|---|
| 2024-12-31 | $26.50M derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-20 | $78.34M derived: sum of 2 quarters · filed 2025-02-20 | $110.10M derived: sum of 3 quarters · filed 2025-02-20 | $102.98M 10-K · filed 2025-02-20 | ||
| 2024-09-30 | $51.84M 10-Q · filed 2024-11-05 | $83.60M derived: sum of 2 quarters · filed 2024-11-05 | $76.48M 10-Q · filed 2024-11-05 | $91.15M derived: sum of 4 quarters · filed 2025-02-20 | ||
| 2024-06-30 | $31.76M 10-Q · filed 2024-08-06 | $24.64M 10-Q · filed 2024-08-06 | $39.31M derived: sum of 3 quarters · filed 2025-02-20 | $40.31M derived: sum of 4 quarters · filed 2025-02-20 | ||
| 2024-03-31 | -$7.12M 10-Q · filed 2024-05-07 | $7.55M derived: sum of 2 quarters · filed 2025-02-20 | $8.55M derived: sum of 3 quarters · filed 2025-02-20 | $66.26M derived: sum of 4 quarters · filed 2025-02-20 | ||
| 2023-12-31 | $14.67M derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-20 | $15.67M derived: sum of 2 quarters · filed 2025-02-20 | $73.38M derived: sum of 3 quarters · filed 2025-02-20 | $122.87M 10-K · filed 2025-02-20 | ||
| 2023-09-30 | $998.00K 10-Q · filed 2024-11-05 | $58.71M derived: sum of 2 quarters · filed 2024-11-05 | $108.20M 10-Q · filed 2024-11-05 | $157.90M derived: sum of 4 quarters · filed 2025-02-20 | ||
| 2023-06-30 | $57.71M 10-Q · filed 2024-08-06 | $106.84M 10-Q · filed 2024-08-06 | $156.91M derived: sum of 3 quarters · filed 2025-02-20 | $204.34M derived: sum of 4 quarters · filed 2025-02-20 | ||
| 2023-03-31 | $49.13M 10-Q · filed 2024-05-07 | $99.19M derived: sum of 2 quarters · filed 2025-02-20 | $146.63M derived: sum of 3 quarters · filed 2025-02-20 | |||
| 2022-12-31 | $50.06M derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-20 | $97.50M derived: sum of 2 quarters · filed 2025-02-20 | $190.17M 10-K · filed 2025-02-20 | |||
| 2022-09-30 | $47.43M 10-Q · filed 2023-11-07 | $140.10M 10-Q · filed 2023-11-07 | ||||
| 2021-12-31 | $149.19M 10-K · filed 2024-02-21 | |||||
| 2013-06-30 | $7.43M 10-Q · filed 2013-08-02 | $27.32M 10-Q · filed 2013-08-02 | $48.08M derived: sum of 3 quarters · filed 2013-08-02 | $64.57M derived: sum of 4 quarters · filed 2013-08-02 | ||
| 2013-03-31 | $19.89M 10-Q · filed 2013-05-03 | $40.66M derived: sum of 2 quarters · filed 2013-06-13 | $57.15M derived: sum of 3 quarters · filed 2013-06-13 | $76.15M derived: sum of 4 quarters · filed 2013-08-02 | ||
| 2012-12-31 | $20.77M derived: 10-K/A 12 month − 10-Q 9 month · filed 2013-06-13 | $37.25M derived: sum of 2 quarters · filed 2013-06-13 | $56.26M derived: sum of 3 quarters · filed 2013-08-02 | $73.83M 10-K/A · filed 2013-06-13 | ||
| 2012-09-30 | $16.49M 10-Q · filed 2012-11-02 | $35.49M derived: sum of 2 quarters · filed 2013-08-02 | $53.06M 10-Q · filed 2012-11-02 | $66.63M derived: sum of 4 quarters · filed 2013-08-02 | ||
| 2012-06-30 | $19.00M 10-Q · filed 2013-08-02 | $15.73M 10-Q/A · filed 2012-09-19 | $36.58M 10-Q · filed 2013-08-02 | $30.28M 10-Q/A · filed 2012-09-19 | $50.15M derived: sum of 3 quarters · filed 2013-08-02 | $67.01M derived: sum of 4 quarters · filed 2013-08-02 |
| 2012-03-31 | $17.58M 10-Q · filed 2013-05-03 | $31.15M derived: sum of 2 quarters · filed 2013-06-13 | $48.01M derived: sum of 3 quarters · filed 2013-06-13 | $61.18M derived: sum of 4 quarters · filed 2013-06-13 | ||
| 2011-12-31 | $13.57M derived: 10-K/A 12 month − 10-Q 9 month · filed 2013-06-13 | $30.43M derived: sum of 2 quarters · filed 2013-06-13 | $43.60M derived: sum of 3 quarters · filed 2013-06-13 | $60.78M 10-K/A · filed 2013-06-13 | ||
| 2011-09-30 | $16.86M 10-Q · filed 2012-11-02 | $30.03M derived: sum of 2 quarters · filed 2012-11-02 | $47.21M 10-Q · filed 2012-11-02 | |||
| 2011-06-30 | $13.17M 10-Q/A · filed 2012-09-19 | $25.12M 10-Q/A · filed 2012-09-19 | ||||
| 2010-12-31 | $54.46M 10-K/A · filed 2013-06-13 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| INSULET CORP (PODD) | United States | $9.420B | 28.12 |
| GLAUKOS Corp (GKOS) | United States | $9.135B | -43.73 |
| BAXTER INTERNATIONAL INC (BAX) | United States | $12.139B | -10.35 |
| Penumbra Inc (PEN) | United States | $12.596B | 77.33 |
| MiniMed Group, Inc. (MMED) | United States | $5.748B | -16.85 |
| MERIT MEDICAL SYSTEMS INC (MMSI) | United States | $5.212B | 28.44 |
| TELEFLEX INC (TFX) | United States | $5.093B | -5.44 |
| Solventum Corp (SOLV) | United States | $15.085B | 9.16 |
| HAEMONETICS CORP (HAE) | United States | $4.821B | 36.52 |
| Heartflow, Inc. (HTFL) | United States | $4.225B |